COMMAND: A phase II randomized, double-blind, placebo-controlled, multicenter study of defactinib as maintenance therapy in subjects with malignant pleural mesothelioma that has not progressed on at least four cycles of pemetrexed/platinum therapy Meeting Abstract
| Authors: | Fennell, D. A.; Baas, P.; Kindler, H. L.; Krug, L. M.; Nowak, A.; Zauderer, M.; Gralla, R. J.; Keegan, M.; Horobin, J. |
| Abstract Title: | COMMAND: A phase II randomized, double-blind, placebo-controlled, multicenter study of defactinib as maintenance therapy in subjects with malignant pleural mesothelioma that has not progressed on at least four cycles of pemetrexed/platinum therapy |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613202196 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.tps7611 |
| Notes: | Meeting Abstract: TPS7611 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work